Brainsway Ltd (BWAY) - News Archive

In a significant advancement in the field of mental health treatment, BrainsWay Ltd has received FDA clearance for its Deep Transcranial Magnetic Stimulation (Deep TMS) technology as an adjunct therapy for Major Depress...

In a noteworthy advancement for the field of mental health treatment, BrainsWay Ltd. (NASDAQ & TASE: BWAY), a prominent player in non-invasive brain disorder therapies, unveiled positive independent pilot data from a st...

: Emerging evidence suggests that Deep Transcranial Magnetic Stimulation (Deep TMS) may offer a promising alternative for managing pain symptoms, particularly in patients with comorbid mental health disorders. Recent fe...

BrainsWay Ltd. is charting an ambitious course as a leader in the realm of noninvasive neurostimulation treatments. With a strategic push to expand its presence in East Asia, complemented by a robust network growth in t...

BrainsWayns Strategic Expansion and Financial Maneuvering: A New Chapter in Mental Health CareIn a rapidly changing landscape where mental health issues dominate societal concerns, BrainsWay Ltd. is poised to solidify i...

In a striking move indicative of the rapidly evolving landscape of mental health treatment, BrainsWay, a leader in innovative transcranial magnetic stimulation (TMS) technologies, has announced a significant expansion i...

BrainsWay Pioneers New Frontiers in Mental Health Therapy as Israel’s Defense Ministry Endorses TMS for PTSDnnIn a significant advancement for mental health treatment in Israel, BrainsWay Ltd. a prominent player in the...

BrainsWay, a leading provider of advanced neurostimulation treatments, recently appointed Dr. Richard A. Bermudes as its Chief Medical Officer. With decades of experience in the field of Transcranial Magnetic Stimulatio...

BrainsWay Ltd., a renowned global leader in noninvasive neurostimulation therapies for mental health disorders, has recently announced its strategic entry into the Canadian market. The company has signed an exclusive mu...

BURLINGTON, Mass. and JERUSALEM, Jan. 10, 2024 BrainsWay Ltd. (NASDAQ & TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, has announced strategic advancements...

Expanded FDA Clearance for Deep TMS: A New Frontier in Treating Late-Life Depression Background and SignificanceTranscranial magnetic stimulation (TMS) has been recognized as an effective treatment modality for major de...

In a groundbreaking publication, BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, has revealed the potential of their Deep Transcranial Magnetic Stimulatio...

In the ever-evolving landscape of mental health treatment, BrainsWay Ltd and Katies Way have emerged as groundbreaking leaders, making significant strides in providing lifesaving mental health treatment nationally, with...

In recent years, advancements in neurostimulation treatments have gained significant attention in the field of mental health disorders. BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments...

BrainsWay Ltd., a renowned global leader in advanced noninvasive neurostimulation treatments for mental health disorders, has announced its increased collaboration with a growing mental health treatment provider in the...

BrainsWay Announces Expansion of Deep TMS Technology in South Korea: Bolstering Mental Health Treatment OptionsIn a significant move towards advancing mental health treatments, BrainsWay Ltd., a global leader in advance...